Song Juhyun, Cho Kyoung Joo, Oh Yumi, Lee Jong Eun
Department of Anatomy, Yonsei University College of Medicine, Seoul, South Korea.
Department of Anatomy, Yonsei University College of Medicine, Seoul, South Korea; BK21 Plus Project for Medical Sciences, and Brain Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
Biochem Biophys Res Commun. 2015 Jul 10;462(4):396-401. doi: 10.1016/j.bbrc.2015.05.004. Epub 2015 May 11.
Neural stem cells (NSCs) have the potential for differentiation into neurons known as a groundbreaking therapeutic solution for central nervous system (CNS) diseases. To resolve the therapeutic efficiency of NSCs, recent researchers have focused on the study on microRNA's role in CNS. Some micro RNAs have been reported significant functions in NSC self-renewal and differentiation through the post-transcriptional regulation of neurogenesis genes. MicroRNA-Let7a (Let7a) has known as the regulator of diverse cellular mechanisms including cell differentiation and proliferation. In present study, we investigated whether Let7a regulates NSC differentiation by targeting the nuclear receptor TLX, which is an essential regulator of NSC self-renewal, proliferation and differentiation. We performed the following experiments: western blot analysis, TaqMan assay, RT-PCR, and immunocytochemistry to confirm the alteration of NSCs. Our data showed that let7a play important roles in controlling NSC fate determination. Thus, manipulating Let-7A and TLX could be a novel strategy to enhance the efficiency of NSC's neuronal differentiation for CNS disorders.
神经干细胞(NSCs)具有分化为神经元的潜力,这被认为是治疗中枢神经系统(CNS)疾病的一种开创性治疗方法。为了提高神经干细胞的治疗效率,最近的研究人员专注于研究微小RNA在中枢神经系统中的作用。一些微小RNA已被报道通过对神经发生基因的转录后调控,在神经干细胞的自我更新和分化中发挥重要作用。微小RNA-Let7a(Let7a)已知是包括细胞分化和增殖在内的多种细胞机制的调节因子。在本研究中,我们研究了Let7a是否通过靶向核受体TLX来调节神经干细胞的分化,TLX是神经干细胞自我更新、增殖和分化的重要调节因子。我们进行了以下实验:蛋白质免疫印迹分析、TaqMan检测、逆转录-聚合酶链反应(RT-PCR)和免疫细胞化学,以确认神经干细胞的变化。我们的数据表明,Let7a在控制神经干细胞命运决定中起重要作用。因此,操纵Let-7A和TLX可能是提高神经干细胞向神经元分化效率以治疗中枢神经系统疾病的一种新策略。